ARIELLE SPROTT: Open Payments
NPI 1568921013 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,743 in 45 payments from 10 companies in 2025. Trend: 2023 $1,870 · 2024 $1,603 · 2025 $1,743
Food & beverage: $1,203Consulting: $540
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 1 | $540 |
| Exelixis Inc. | 31 | $463 |
| Astellas Pharma US Inc | 3 | $244 |
| PFIZER INC. | 3 | $157 |
| Janssen Biotech, Inc. | 2 | $138 |
| Merck Sharp & Dohme LLC | 1 | $90 |
| Eisai Inc. | 1 | $30 |
| TOLMAR, INC. | 1 | $27 |
| pharmaand GmbH | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
Products named: ERLEADA, CABOMETYX, PADCEV, Xtandi, RYBREVANT, KEYTRUDA, RUBRACA, Lenvima.
Industry payments across TX — which companies pay providers there.
